The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II trial investigating safety and efficacy of autologous TAC01-HER2 in relapsed or refractory solid tumors.
 
Benjamin L. Schlechter
Honoraria - Quercegen Pharmaceuticals
 
Daniel Olson
Consulting or Advisory Role - Gerson Lehrman Group; Iovance Biotherapeutics; MJH Life Sciences; Novartis
 
Mridula Annette George
Consulting or Advisory Role - OBI Pharma; Seagen
Research Funding - Incyte; Oncolytics
Travel, Accommodations, Expenses - OBI Pharma; OBI Pharma
Other Relationship - Oncology Learning Network
 
Sam Saibil
No Relationships to Disclose
 
Antonio Giordano
Consulting or Advisory Role - Pfizer
 
Riemke Bouvier
No Relationships to Disclose
 
Miriam Gavriliuc
No Relationships to Disclose
 
Brooke Pieke
No Relationships to Disclose
 
Kelly Gruber
Employment - Bristol Myers Squibb; Celularity Inc.
 
Emily Lichtenstein
No Relationships to Disclose
 
Maria Apostolopoulou
Employment - Triumvira Immunologics, Inc
Patents, Royalties, Other Intellectual Property - Wang X, Apostolopoulou M, Wetherby K (filed 03/21/2019) Apparatus and method for collecting multi-tiered particles from a biological sample. U.S. Provisional Pat. Ser. No. 62/821,598
 
Kara M. Moss
Employment - Triumvira Immunologics, Inc
Stock and Other Ownership Interests - Triumvira Immunologics, Inc
Travel, Accommodations, Expenses - Triumvira Immunologics, Inc
 
Nathan Ternus
Employment - Triumvira Immunologics, Inc
 
Deyaa R Adib
Employment - Triumvira Immunologics, Inc
 
Ecaterina Elena Dumbrava
Consulting or Advisory Role - Bolt Biotherapeutics
Research Funding - Aileron Therapeutics (Inst); Amgen (Inst); Aprea Therapeutics (Inst); Astex Pharmaceuticals (Inst); Bayer (Inst); Bellicum Pharmaceuticals (Inst); Bolt Biotherapeutics (Inst); Compugen (Inst); Gateway Foundation (Inst); Immunocore (Inst); Immunomedics/Gilead (Inst); Mereo BioPharma 5 (Inst); PMV Pharma (Inst); Rain Therapeutics (Inst); Sanofi (Inst); Seagen (Inst); TRACON Pharma (Inst); Triumvira Immunologics, Inc (Inst); Unum Therapeutics (Inst)